Malignancy, cancer, carcinoma, hepatocarcinoma, liver cancer, metastasis Cancer, colon cancer, liver cancer, metastasis
Conditions
Interventions
Sponsors
OLVG
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Anticipated minor or technically major liver resection (less than 3 bordering anterolateral (2,3,4b,5 and 6 or posterior-superior (1,4a,7 and 8) segments)Procedure not combined with microwave ablationNo simultanious colon resectionNo usage of anticoagulantsASA Classification I or IIPatient is able to use an ear thermometer and pulse-oxymeterPatient has an informal caregiver (e.g. partner, family member, friend) present for the first 24 hours after surgeryPatient resides within a 45-minute drive from the OLVG Hospital
Exclusion criteria
Exclusion criteria: Patients younger than 18 years oldPatient does not wish to undergo SDDSecondary exclusion criteriaResection is more extensive than anticipated (major liver resection, i.e. > 3 bordering anatomical segments resected)Intraoperative blood loss exceeding 500ccOperating time exceeds 4 hoursBile leakage or risk of postoperative haemorrhage necessitating postoperative drainage or anesthesiological complications.Abnormal vital signs (tachycardia >100, temperature above 38.4 Celsius, hypotension at the end of the afternoon) or drop in Hemoglobin level >1 point 6 hours postoperativelyPostoperative vomiting, wound problems, excess pain, or other causes of doubt.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In this present study the primary outcome is the percentage of successful SDD with usage of remote monitoring. Successful SDD was defined as SDD without readmission within 48 hours. This endpoint is chosen to assess the feasibility of the concept in current practice. SDD is considered feasible if >75% successful SDD can be applied in the selected patient group. | — |
Secondary
| Measure | Time frame |
|---|---|
| To obtain information about the safety of SDD and remote monitoring of the selected group of patients undergoing hepatic surgery we will analyse adverse outcomes including complications ranked in the Clavien-Dindo classification, emergency room presentations, readmissions, reoperations and mortality. Furthermore, monitoring of time to detection of the complication and prompt treatment is necessary as these factors contribute to the patient’s outcome. We will evaluate patient satisfaction and experience with the hospital care around SDD by using the QoR-15 Patient Survey. The questionnaire will be given to patients after the operation, this composed questionnaire consisting of two sections, involving 10-point Likert scale questions. The QoR-15 Patient survey is a validated and efficient measurement of postoperative recovery. | — |
Countries
Netherlands
Contacts
Public ContactB.W. Verboeket
OLVG
Outcome results
None listed